Proptosis and decreased vision secondary to prostate cancer orbital wall metastasis

Asmita R. Patel, Karin B. Olson, Kenneth Pienta

Research output: Contribution to journalArticle

Abstract

The case of a 66-year-old gentleman who presented with unilateral proptosis, eye pain and partial loss of vision seven years after his original prostate cancer diagnosis is reported. MRI of the orbits revealed a 2-cm lesion in the posterolateral right orbital wall near the optic foramen with compression of the optic nerve. Metastatic orbital lesions are relatively uncommon in prostate cancer. Treatment is palliative and varies according to the time of presentation in the course of the disease. This patient's symptoms resolved after reinitiation of combined androgen blockade.

Original languageEnglish (US)
Pages (from-to)3521-3522
Number of pages2
JournalAnticancer Research
Volume25
Issue number5
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Exophthalmos
Prostatic Neoplasms
Eye Pain
Neoplasm Metastasis
Orbit
Optic Nerve
Palliative Care
Androgens

Keywords

  • Bone metastasis
  • Prostate cancer
  • Vision loss

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Proptosis and decreased vision secondary to prostate cancer orbital wall metastasis. / Patel, Asmita R.; Olson, Karin B.; Pienta, Kenneth.

In: Anticancer Research, Vol. 25, No. 5, 09.2005, p. 3521-3522.

Research output: Contribution to journalArticle

Patel, Asmita R. ; Olson, Karin B. ; Pienta, Kenneth. / Proptosis and decreased vision secondary to prostate cancer orbital wall metastasis. In: Anticancer Research. 2005 ; Vol. 25, No. 5. pp. 3521-3522.
@article{08a2316b681a4231a0efbdf96ab7fb1d,
title = "Proptosis and decreased vision secondary to prostate cancer orbital wall metastasis",
abstract = "The case of a 66-year-old gentleman who presented with unilateral proptosis, eye pain and partial loss of vision seven years after his original prostate cancer diagnosis is reported. MRI of the orbits revealed a 2-cm lesion in the posterolateral right orbital wall near the optic foramen with compression of the optic nerve. Metastatic orbital lesions are relatively uncommon in prostate cancer. Treatment is palliative and varies according to the time of presentation in the course of the disease. This patient's symptoms resolved after reinitiation of combined androgen blockade.",
keywords = "Bone metastasis, Prostate cancer, Vision loss",
author = "Patel, {Asmita R.} and Olson, {Karin B.} and Kenneth Pienta",
year = "2005",
month = "9",
language = "English (US)",
volume = "25",
pages = "3521--3522",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Proptosis and decreased vision secondary to prostate cancer orbital wall metastasis

AU - Patel, Asmita R.

AU - Olson, Karin B.

AU - Pienta, Kenneth

PY - 2005/9

Y1 - 2005/9

N2 - The case of a 66-year-old gentleman who presented with unilateral proptosis, eye pain and partial loss of vision seven years after his original prostate cancer diagnosis is reported. MRI of the orbits revealed a 2-cm lesion in the posterolateral right orbital wall near the optic foramen with compression of the optic nerve. Metastatic orbital lesions are relatively uncommon in prostate cancer. Treatment is palliative and varies according to the time of presentation in the course of the disease. This patient's symptoms resolved after reinitiation of combined androgen blockade.

AB - The case of a 66-year-old gentleman who presented with unilateral proptosis, eye pain and partial loss of vision seven years after his original prostate cancer diagnosis is reported. MRI of the orbits revealed a 2-cm lesion in the posterolateral right orbital wall near the optic foramen with compression of the optic nerve. Metastatic orbital lesions are relatively uncommon in prostate cancer. Treatment is palliative and varies according to the time of presentation in the course of the disease. This patient's symptoms resolved after reinitiation of combined androgen blockade.

KW - Bone metastasis

KW - Prostate cancer

KW - Vision loss

UR - http://www.scopus.com/inward/record.url?scp=23344440449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23344440449&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 3521

EP - 3522

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -